BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20530655)

  • 1. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications.
    Russell HC; Chadha V; Lockington D; Kemp EG
    Br J Ophthalmol; 2010 Oct; 94(10):1316-21. PubMed ID: 20530655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
    Ditta LC; Shildkrot Y; Wilson MW
    Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ocular surface squamous neoplasia with Mitomycin C.
    Gupta A; Muecke J
    Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
    Tseng SH; Tsai YY; Chen FK
    Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.
    Rahimi F; Alipour F; Ghazizadeh Hashemi H; Hashemian MN; Mehrdad R
    Arch Iran Med; 2009 Jan; 12(1):55-9. PubMed ID: 19111031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periocular allergic contact dermatitis following topical Mitomycin C eye drop application.
    Cumurcu T; Sener S; Cavdar M
    Cutan Ocul Toxicol; 2011 Sep; 30(3):239-40. PubMed ID: 21309691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical mitomycin C for the treatment of conjunctival tumor.
    Ozcan AA; Sizmaz S; Yagmur M
    Ophthalmologica; 2007; 221(1):14-7. PubMed ID: 17183195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.
    Birkholz ES; Goins KM; Sutphin JE; Kitzmann AS; Wagoner MD
    Cornea; 2011 Jan; 30(1):37-41. PubMed ID: 20861726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The topical application of mitomycin C in the treatment of scar formation and stenosis in hollow organs of the head and neck: a field report].
    Bast F; Risteska K; Jovanovic S; Sedlmaier B
    Laryngorhinootologie; 2009 Aug; 88(8):528-33. PubMed ID: 19554503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
    Lichtinger A; Pe'er J; Frucht-Pery J; Solomon A
    Ophthalmology; 2010 Mar; 117(3):431-7. PubMed ID: 20060167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias.
    Kemp EG; Harnett AN; Chatterjee S
    Br J Ophthalmol; 2002 Jan; 86(1):31-4. PubMed ID: 11801499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical mitomycin-C for pterygia: is single application appropriate?
    Rubinfeld RS; Stein RM
    Ophthalmic Surg Lasers; 1997 Aug; 28(8):662-9. PubMed ID: 9268998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
    Dudney BW; Malecha MA
    Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical mitomycin following cryotherapy for treatment of recurrent ocular surface melanoma.
    Rudkin AK; Muecke JS
    Can J Ophthalmol; 2009 Oct; 44(5):e41. PubMed ID: 19798814
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium.
    Helal M; Messiha N; Amayem A; el-Maghraby A; Elsherif Z; Dabees M
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):674-8. PubMed ID: 8858633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epiphora as a side effect of topical mitomycin C.
    Kopp ED; Seregard S
    Br J Ophthalmol; 2004 Nov; 88(11):1422-4. PubMed ID: 15489486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective comparison of surgical removal and subsequent CO2 laser ablation versus topical administration of mitomycin C as therapy for equine corneolimbal squamous cell carcinoma.
    Clode AB; Miller C; McMullen RJ; Gilger BC
    Vet Ophthalmol; 2012 Jul; 15(4):254-62. PubMed ID: 22151345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
    Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
    Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.